Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sars-Cov2 Neuroinvasiveness in COVID-19 Patients
NCT04427254Terminated
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Jun 2020
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Adolphe de Rothschild Foundation Hospital. Primary endpoint: Percentage of patients with COVID-19 positive samples/biopsies at 0 weeks. Started Jun 2020; status: terminated.
Beyond the preview
Go deeper on NCT04427254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427254.